Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BY 4.0Biomolecules

Mitochondrial Injury and Inflammation–Fibrosis Coupling in Diabetic Kidney Disease: Cell Type-Specific Mechanisms and Therapeutic Implications

  1. 1Northeast Asia Research Institute of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130117, China

Abstract

Altered mitochondrial metabolism, impaired quality control, and persistent inflammation are closely associated with diabetic kidney disease (DKD). This narrative review examines how these processes differ across renal cell populations and disease contexts, and considers their implications for treatment. We organize the evidence around three overlapping functional states: compensatory adaptation, metabolic vulnerability, and functional decompensation. Each is characterized by a combination of energetic capacity, respiratory reserve, substrate flexibility, and the ability to clear damaged mitochondria. The proposed states offer a testable conceptual framework; they do not constitute a validated biological sequence or clinical staging system. Mechanistic evidence is most extensive in podocytes and proximal tubular epithelial cells, whereas direct evidence in mesangial cells, the distal nephron, and immune-interstitial compartments remain more limited. Experimental studies support individual connections between mitochondrial danger signaling, regulated cell death, senescence, and fibrosis, but rarely establish the entire temporal sequence in a single model. In assessing established therapies, experimental agents, and botanical preparations, we distinguish clinical kidney benefits from mitochondrial functional effects, causal pathway dependence, and direct target engagement. This synthesis supports tailoring interventions to the affected cell population and its remaining adaptive capacity, while testing mitochondrial mediation separately from kidney protection.

Related

  1. Mitochondrial Dynamics in Diabetes Mellitus and Its Complications: Mechanisms, Pathological Roles, and Therapeutic Implications.
    Guohua Wang, Yige Zhao, Gaiting Liu +5
    International journal of molecular sciencesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  2. Metabolic Remodeling in Peritoneal Dialysis-Associated Peritoneal Fibrosis: Mechanisms, Candidate Metabolic Signatures, and Therapeutic Perspectives
    Zhengjie Zhu, Mengyang Wang, Tao Zhang +3
    MetabolitesPeer-reviewedCC BYFull textProteomics & metabolomicsEurope PMC
  3. Mitochondrial cristae remodeling in ischemic stroke: mechanisms and therapeutic perspectives
    Dawei Zhang, Hongbo Zhang, Ruoxin Tu +5
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefPMCEurope PMC
  4. Circular RNAs in tumor biology and immunology: molecular mechanisms and therapeutic implications
    Zhenyan Jiang, Yong Peng, Xiaojuan Yang
    Molecular CancerPeer-reviewedCC BYFull text1 citedMolecular biology & gene regulationDOAJ
  5. Short-chain fatty acids and intestinal macrophage immunometabolism in metabolic syndrome: mechanisms and implications for chronic low-grade inflammation
    Jiaxin Ma, Chen Li, Hongjun Lou
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefPMC
BibTeX
@article{nie2026mitochondrial,
  title = {{Mitochondrial Injury and Inflammation–Fibrosis Coupling in Diabetic Kidney Disease: Cell Type-Specific Mechanisms and Therapeutic Implications}},
  author = {Weichen Nie and Zihan Wang and Lu Ding and Yuchi Zhou and Yuxin Guo and Min Li and Xiangmu Gai and Zeyu Wang and Xiangyan Li},
  journal = {Biomolecules},
  year = {2026},
  month = nov,
  doi = {10.3390/biom16111638},
  url = {https://www.mdpi.com/2218-273X/16/11/1638},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Mitochondrial Injury and Inflammation–Fibrosis Coupling in Diabetic Kidney Disease: Cell Type-Specific Mechanisms and Therapeutic Implications
AU  - Weichen Nie
AU  - Zihan Wang
AU  - Lu Ding
AU  - Yuchi Zhou
AU  - Yuxin Guo
AU  - Min Li
AU  - Xiangmu Gai
AU  - Zeyu Wang
AU  - Xiangyan Li
PY  - 2026
DA  - 2026/11/10
JO  - Biomolecules
DO  - 10.3390/biom16111638
UR  - https://www.mdpi.com/2218-273X/16/11/1638
AB  - Altered mitochondrial metabolism, impaired quality control, and persistent inflammation are closely associated with diabetic kidney disease (DKD). This narrative review examines how these processes differ across renal cell populations and disease contexts, and considers their implications for treatment. We organize the evidence around three overlapping functional states: compensatory adaptation, metabolic vulnerability, and functional decompensation. Each is characterized by a combination of energetic capacity, respiratory reserve, substrate flexibility, and the ability to clear damaged mitochondria. The proposed states offer a testable conceptual framework; they do not constitute a validated biological sequence or clinical staging system. Mechanistic evidence is most extensive in podocytes and proximal tubular epithelial cells, whereas direct evidence in mesangial cells, the distal nephron, and immune-interstitial compartments remain more limited. Experimental studies support individual connections between mitochondrial danger signaling, regulated cell death, senescence, and fibrosis, but rarely establish the entire temporal sequence in a single model. In assessing established therapies, experimental agents, and botanical preparations, we distinguish clinical kidney benefits from mitochondrial functional effects, causal pathway dependence, and direct target engagement. This synthesis supports tailoring interventions to the affected cell population and its remaining adaptive capacity, while testing mitochondrial mediation separately from kidney protection.
SN  - 2218-273X
ER  -